These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26958088)

  • 1. Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer.
    Kanyong P; Rawlinson S; Davis J
    J Cancer; 2016; 7(5):523-31. PubMed ID: 26958088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Clinically Significant Prostate Cancer by Combined
    Kotova ES; Savochkina YA; Doludin YV; Vasilyev AO; Prilepskay EA; Potoldykova NV; Babalyan KA; Kanygina AV; Morozov AO; Govorov AV; Enikeev DV; Kostryukova ES; Ilina EN; Govorun VM; Pushkar DY; Sharova EI
    Res Rep Urol; 2020; 12():403-413. PubMed ID: 32984088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience.
    Ji J; Chen X; Xu Y; Cao Z; Xu H; Kong C; Wang F; Sun Y
    Cancer Control; 2019; 26(1):1073274819887697. PubMed ID: 31793344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer.
    Ouyang B; Bracken B; Burke B; Chung E; Liang J; Ho SM
    J Urol; 2009 Jun; 181(6):2508-13; discussion 2513-4. PubMed ID: 19371911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Prostate Cancer Antigen 3 as a Tumour Marker: Biochemical and Clinical Aspects.
    Schmid M; Hansen J; Chun FK
    Adv Exp Med Biol; 2015; 867():277-89. PubMed ID: 26530372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
    Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor.
    Lin PY; Cheng KL; McGuffin-Cawley JD; Shieu FS; Samia AC; Gupta S; Cooney M; Thompson CL; Liu CC
    Biosensors (Basel); 2012 Sep; 2(4):377-87. PubMed ID: 25586028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prostate cancer biomarkers in undiagnosed men.
    Dani H; Loeb S
    Curr Opin Urol; 2017 May; 27(3):210-216. PubMed ID: 28212119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer potential biomarkers in prostate cancer.
    Wright JL; Lange PH
    Rev Urol; 2007; 9(4):207-13. PubMed ID: 18231617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-methylacyl-CoA racemase and hepsin as urinary prostate cancer markers.
    Sroka WD; Adamowski M; Słupski P; Siódmiak J; Jarzemski P; Odrowąż-Sypniewska G; Marszałł MP
    Int J Biol Markers; 2015 Nov; 30(4):e401-6. PubMed ID: 25982684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioconjugated, Single-Use Biosensor for the Detection of Biomarkers of Prostate Cancer.
    Yao J; Wang Y; Dai Y; Liu CC
    ACS Omega; 2018 Jun; 3(6):6411-6418. PubMed ID: 30023946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.
    Sreekumar A; Laxman B; Rhodes DR; Bhagavathula S; Harwood J; Giacherio D; Ghosh D; Sanda MG; Rubin MA; Chinnaiyan AM
    J Natl Cancer Inst; 2004 Jun; 96(11):834-43. PubMed ID: 15173267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
    Stewart J; Fleshner N; Cole H; Toi A; Sweet J
    J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate diagnosis of prostate cancer with CRISPR-based nucleic acid test strip by simultaneously identifying PCA3 and KLK3 genes.
    Chen W; Wu S; Li G; Duan X; Sun X; Li S; Zhao Y; Gu D; Zeng G; Liu H
    Biosens Bioelectron; 2023 Jan; 220():114854. PubMed ID: 36327902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa).
    Stephan C; Rittenhouse H; Hu X; Cammann H; Jung K
    EJIFCC; 2014 Apr; 25(1):55-78. PubMed ID: 27683457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers.
    Roberts MJ; Richards RS; Chow CW; Doi SA; Schirra HJ; Buck M; Samaratunga H; Perry-Keene J; Payton D; Yaxley J; Lavin MF; Gardiner RA
    Prostate Int; 2016 Sep; 4(3):97-102. PubMed ID: 27689066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience.
    Ramos CG; Valdevenito R; Vergara I; Anabalon P; Sanchez C; Fulla J
    Urol Oncol; 2013 Nov; 31(8):1522-6. PubMed ID: 22687565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer.
    Yang D; Shi X; Lei Y; Zhou X; Chen Q
    Oncol Lett; 2020 Aug; 20(2):1418-1422. PubMed ID: 32724384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.